Inhibition of autophagy enhances the anticancer effect of Schisandrin B on head and neck squamous cell carcinoma
Journal of Biochemical and Molecular Toxicology · 2024
DOI: 10.1002/jbt.23585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Mengmeng Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of Chin…. Hauptthemen laut MEDLINE: NF-kappa B, Head and Neck Neoplasms, Polycyclic Compounds, Lignans. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The Xiangya Clinical Big Data System construction project, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Head and neck squamous cell carcinoma (HNSCC) is among the most common malignant tumors worldwide and has a poor prognosis. Autophagy regulation has been proposed as a possible treatment option for HNSCC. Schisandrin B (Sch B) exerts anticancer effects by regulating apoptosis and autophagy, but the anticancer effect of Sch B in HNSCC remains unclear. This study aimed to investigate the effects of Sch B on human Cal27 HNSCC cells and to further reveal its potential regulatory mechanisms. The anticancer effect of Sch B was evaluated in vitro by flow cytometry, clonogenic assays, and Western blot analysis. The regulatory mechanism of Sch B‐induced apoptosis and autophagy was further explored by polymerase chain reaction, luciferase assay, and reactive oxygen species (ROS) detection. The results showed that Sch B significantly induced apoptosis and autophagy in Cal27 cells and that inhibition of autophagy enhanced the apoptotic effect of Sch B on Cal27 cells. Additionally, Sch B‐activated autophagy in Cal27 cells was dependent on the nuclear factor‐kappa B (NF‐κB) pathway, and ROS acted as a regulator of the NF‐B pathway. N‐acetylcysteine, a scavenger of ROS, inhibited Sch B‐dependent autophagy via the NF‐κB pathway. Based on the results, Sch B is a potential therapeutic agent for HNSCC and activates the NF‐κB pathway by increasing ROS production, which subsequently promotes autophagy in HNSCC cells. Therefore, the strategy of enhancing the anticancer effect of Sch B by inhibiting autophagy deserves further attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Förderung
- National Natural Science Foundation of China
- The Xiangya Clinical Big Data System construction project
- Natural Science Foundation of Hunan Province
Zitieren
APA
Li, M., Tang, Q., Li, S., Yang, X., Zhang, Y., Tang, X., Huang, P., & Yin, D. (2024). Inhibition of autophagy enhances the anticancer effect of Schisandrin B on head and neck squamous cell carcinoma. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23585
Vancouver
Li M, Tang Q, Li S, Yang X, Zhang Y, Tang X, et al. Inhibition of autophagy enhances the anticancer effect of Schisandrin B on head and neck squamous cell carcinoma. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23585
BibTeX
@article{Li2024,
author = {Li, Mengmeng and Tang, Qinglai and Li, Shisheng and Yang, Xinming and Zhang, Ying and Tang, Xiaojun and Huang, Peiying and Yin, Danhui},
title = {Inhibition of autophagy enhances the anticancer effect of Schisandrin B on head and neck squamous cell carcinoma},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2024},
doi = {10.1002/jbt.23585}
}
EUVIMED